^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Nasopharyngeal Carcinoma |
| Drug: | cisplatin (DNA synthesis inhibitor) + paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) + epirubicin (Topoisomerase II inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Nasopharyngeal cancer: Induction/Sequential Systemic Therapy…Other recommended regimens…Cisplatin/epirubicin/paclitaxel
